𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Leg length, cognitive impairment and cognitive decline in an African-Caribbean population

✍ Scribed by Zanete Mak; Jae-Min Kim; Robert Stewart


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
75 KB
Volume
21
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Shorter leg length is associated with an adverse environment in early childhood and has been found to be associated with a variety of disorders occurring in mid‐ to late‐life, including dementia in a Korean population. In a community population of African‐Caribbean elders, in whom leg length had been measured, we sought to compare associations with cognitive impairment at baseline and cognitive decline over a three‐year follow‐up period.

Methods

Of 290 African‐Caribbean residents in south London recruited at baseline, 216 (74%) were re‐interviewed after a three‐year period and 203 had sufficient data for this analysis. Cognitive impairment was derived as a binary category from a battery of cognitive tests administered at baseline and cognitive decline was derived from change in performance on a subset of these tests. Leg length (iliac crest to lateral malleolus) was also measured.

Results

Shorter leg length was associated with female sex, lower occupational social class and reported hypertension and diabetes. Shorter leg length (lowest quartile) was significantly associated with cognitive impairment but there were no apparent associations with cognitive decline. The association with cognitive impairment was independent of age, sex and education. Social class appeared to be an important mediating factor.

Conclusions

Shorter leg length may be a marker of early life stressors which result in reduced cognitive reserve. Interestingly this association was mediated more strongly by social class (previous occupational status) than by education in this population. Copyright © 2006 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Markers of inflammation and cognitive de
✍ Vesna Jordanova; Robert Stewart; Emma Davies; Roy Sherwood; Martin Prince 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract ## Background Inflammatory processes may play an important role in cognitive decline and dementia. We investigated the prospective association between levels of three markers of inflammation, plasma interleukin‐6 (IL‐6), serum C‐reactive protein (CRP), serum amyloid A (SAA), and cognit

A systematic review of the prevalence an
✍ Simon Adelman; Martin Blanchard; Gill Livingston 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## Objectives To collate evidence regarding the prevalence and predictors of dementia or relative cognitive impairment in older, African‐Caribbean people in Britain, as compared to their white, British peers. ## Design We conducted a systematic literature review by searching electron

The botany survey: A longitudinal study
✍ Professor John Snowdon; Fred Lane 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 948 KB

An 8-year-long longitudinal study of elderly people in Botany (Sydney) has provided data on the prevalence, incidence and outcome of cognitive impairment and depression in this population. In 1985, a random sample of 146 persons aged 65 years or more, living in their own Lomes, were assessed using t

The validation of an informant screening
✍ Karen Ritchie; Rebecca Fuhrer 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

The performance characteristics of an informant screening test for senile dementia were evaluated within a community-dwelling sample of 583 elderly persons in the Bordeaux region of France. Receiver operating characteristics analysis indicated that although the test performs less well within this co

An examination of the Boston Naming Test
✍ Valerie L. Hobson; James R. Hall; Michelle Harvey; C. Munro Cullum; Laura Lacrit 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Multiple versions of the Boston Naming Test (BNT) exist, which makes comparison of findings from different studies difficult. The current project sought to determine if estimated 60-item BNT scores could be reliably calculated from 30-and 15-item administrations with patients diagnosed with Alzheime